Cargando…

Erratum: Immunotherapy for Glioblastoma: Current Progress and Challenges

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8529955/
https://www.ncbi.nlm.nih.gov/pubmed/34691087
http://dx.doi.org/10.3389/fimmu.2021.782687
_version_ 1784586572487720960
collection PubMed
description
format Online
Article
Text
id pubmed-8529955
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-85299552021-10-22 Erratum: Immunotherapy for Glioblastoma: Current Progress and Challenges Front Immunol Immunology Frontiers Media S.A. 2021-10-07 /pmc/articles/PMC8529955/ /pubmed/34691087 http://dx.doi.org/10.3389/fimmu.2021.782687 Text en Copyright © 2021 Frontiers Production Office https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Erratum: Immunotherapy for Glioblastoma: Current Progress and Challenges
title Erratum: Immunotherapy for Glioblastoma: Current Progress and Challenges
title_full Erratum: Immunotherapy for Glioblastoma: Current Progress and Challenges
title_fullStr Erratum: Immunotherapy for Glioblastoma: Current Progress and Challenges
title_full_unstemmed Erratum: Immunotherapy for Glioblastoma: Current Progress and Challenges
title_short Erratum: Immunotherapy for Glioblastoma: Current Progress and Challenges
title_sort erratum: immunotherapy for glioblastoma: current progress and challenges
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8529955/
https://www.ncbi.nlm.nih.gov/pubmed/34691087
http://dx.doi.org/10.3389/fimmu.2021.782687
work_keys_str_mv AT erratumimmunotherapyforglioblastomacurrentprogressandchallenges